Mimi Zhou
Overview
Explore the profile of Mimi Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang X, Li J, Yao Y, Zhou M, He Y, Zhao Y
J Gastroenterol
. 2025 Jan;
PMID: 39799524
Background: We aim to comprehensively analyze and validate the prognostic efficacy of tetraspanin 4 (TSPAN4) and several other migrasome-related markers in hepatocellular carcinoma (HCC). Methods: The expression, diagnostic, and prognostic...
2.
You S, Zhou M, Xu L, Chen D, Fan M, Huang J, et al.
Nanophotonics
. 2024 Dec;
12(11):2051-2060.
PMID: 39635691
Symmetry-protected bound states in the continuum (SP-BICs) are one of the most intensively studied BICs. Typically, SP-BICs must be converted into quasi-BICs (QBICs) by breaking the unit cell's symmetry so...
3.
Li Z, Qin J, Zhu Y, Zhou M, Zhao N, Zhou E, et al.
Front Microbiol
. 2024 Jul;
15:1424699.
PMID: 38962134
With worldwide cultivation, the faba bean ( L.) stands as one of the most vital cool-season legume crops, serving as a major component of food security. China leads global faba...
4.
Ren X, Li D, Zhou M, Hua H, Li C
BMC Microbiol
. 2024 Jun;
24(1):197.
PMID: 38849732
Background: Emerging evidence emphasized the role of oral microbiome in oral lichen planus (OLP). To date, no dominant pathogenic bacteria have been identified consistently. It is noteworthy that a decreased...
5.
Zhou M, Jie W, Tang F, Zhang S, Mao Q, Liu C, et al.
J Dent Sci
. 2024 Feb;
19(1):254-260.
PMID: 38303872
Background/purpose: The application of artificial intelligence diagnosis based on deep learning in the medical field has been widely accepted. We aimed to evaluate convolutional neural networks (CNNs) for automated classification...
6.
Zhou M, Feng Y, Zhang X, Chen J, Yao N, Fu S, et al.
Oncoimmunology
. 2024 Jan;
13(1):2304963.
PMID: 38235317
Approximately two-thirds of hepatocellular carcinoma (HCC) is considered a "cold tumor" characterized by few tumor-infiltrating T cells and an abundance of immunosuppressive cells. Cilengitide, an integrin αvβ3 inhibitor, has failed...
7.
Deng J, Han Z, Tang H, Yao C, Li X, Xu J, et al.
BMC Gastroenterol
. 2022 Dec;
22(1):521.
PMID: 36526962
Objectives: Dysglycemia promotes the occurrence of fatty liver disease (FLD). However, the process is unclear. This study aimed to analyze the median time-to-onset, cumulative prevalence and influencing factors for the...
8.
Gao N, Deng J, Wang J, Zhou Z, Yao C, Zhou M, et al.
Front Med (Lausanne)
. 2022 Dec;
9:1038475.
PMID: 36457563
Objective: To analyze the prevalence, associated comorbidities, influencing factors, and identifying factors of non-obese fatty liver disease and to provide a reference for its prevention and treatment. Materials And Methods:...
9.
Zhou M, Chen J, Zhang H, Liu H, Yao H, Wang X, et al.
Int J Biol Sci
. 2022 Sep;
18(14):5312-5313.
PMID: 36147471
[This corrects the article DOI: 10.7150/ijbs.45999.].
10.
Goldberg S, Felix N, McCauley M, Eberwine R, Casta L, Haskell K, et al.
Pharmaceutics
. 2021 Oct;
13(10).
PMID: 34683962
Autoimmune diseases such as rheumatoid arthritis are caused by immune system recognition of self-proteins and subsequent production of effector T cells that recognize and attack healthy tissue. Therapies for these...